BAF360 Search Results


90
R&D Systems biotinylated goat anti human ccl20
FIGURE 1. <t>CCL20</t> processing by Cath-D and Cath-B. A, Time course of CCL20 processing by Cath-D and Cath-B. CCL20 (5 M) was incubated with 50 ng of Cath-D or Cath-B at 37°C for the indicated times in buffer I (pH 4.0) or buffer II (pH 6.8), respectively. Pep- statin A (2 M) or CA-074 (5 M) were used as inhib- itors for Cath-D and Cath-B, respectively (I). The cleav- age products were separated by SDS-PAGE and stained with Coomassie blue. B, Reverse phase-HPLC profile of the cleavage products of CCL20 after Cath-D and Cath-B processing. C, CCL20 cleavage sites for Cath-D and Cath-B. The positions of the amino acids located at the cleavage sites are indicated.
Biotinylated Goat Anti Human Ccl20, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/BAF360/Human+CCL20%2FMIP-3+alpha+Biotinylated+Antibody/pm16709808-48-0-6
Average 90 stars, based on 1 article reviews
biotinylated goat anti human ccl20 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
R&D Systems biotinylated goat anti human mip 3α ccl20 polyclonal antibody
FIGURE 1. <t>CCL20</t> processing by Cath-D and Cath-B. A, Time course of CCL20 processing by Cath-D and Cath-B. CCL20 (5 M) was incubated with 50 ng of Cath-D or Cath-B at 37°C for the indicated times in buffer I (pH 4.0) or buffer II (pH 6.8), respectively. Pep- statin A (2 M) or CA-074 (5 M) were used as inhib- itors for Cath-D and Cath-B, respectively (I). The cleav- age products were separated by SDS-PAGE and stained with Coomassie blue. B, Reverse phase-HPLC profile of the cleavage products of CCL20 after Cath-D and Cath-B processing. C, CCL20 cleavage sites for Cath-D and Cath-B. The positions of the amino acids located at the cleavage sites are indicated.
Biotinylated Goat Anti Human Mip 3α Ccl20 Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/BAF360/Human+CCL20%2FMIP-3+alpha+Biotinylated+Antibody/pm11133838-68-20-26
Average 86 stars, based on 1 article reviews
biotinylated goat anti human mip 3α ccl20 polyclonal antibody - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Becton Dickinson baf-360
FIGURE 1. <t>CCL20</t> processing by Cath-D and Cath-B. A, Time course of CCL20 processing by Cath-D and Cath-B. CCL20 (5 M) was incubated with 50 ng of Cath-D or Cath-B at 37°C for the indicated times in buffer I (pH 4.0) or buffer II (pH 6.8), respectively. Pep- statin A (2 M) or CA-074 (5 M) were used as inhib- itors for Cath-D and Cath-B, respectively (I). The cleav- age products were separated by SDS-PAGE and stained with Coomassie blue. B, Reverse phase-HPLC profile of the cleavage products of CCL20 after Cath-D and Cath-B processing. C, CCL20 cleavage sites for Cath-D and Cath-B. The positions of the amino acids located at the cleavage sites are indicated.
Baf 360, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/BAF360/baf+360+antibody/pm20357258-73-51-54
Average 90 stars, based on 1 article reviews
baf-360 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


FIGURE 1. CCL20 processing by Cath-D and Cath-B. A, Time course of CCL20 processing by Cath-D and Cath-B. CCL20 (5 M) was incubated with 50 ng of Cath-D or Cath-B at 37°C for the indicated times in buffer I (pH 4.0) or buffer II (pH 6.8), respectively. Pep- statin A (2 M) or CA-074 (5 M) were used as inhib- itors for Cath-D and Cath-B, respectively (I). The cleav- age products were separated by SDS-PAGE and stained with Coomassie blue. B, Reverse phase-HPLC profile of the cleavage products of CCL20 after Cath-D and Cath-B processing. C, CCL20 cleavage sites for Cath-D and Cath-B. The positions of the amino acids located at the cleavage sites are indicated.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing.

doi: 10.4049/jimmunol.176.11.6512

Figure Lengend Snippet: FIGURE 1. CCL20 processing by Cath-D and Cath-B. A, Time course of CCL20 processing by Cath-D and Cath-B. CCL20 (5 M) was incubated with 50 ng of Cath-D or Cath-B at 37°C for the indicated times in buffer I (pH 4.0) or buffer II (pH 6.8), respectively. Pep- statin A (2 M) or CA-074 (5 M) were used as inhib- itors for Cath-D and Cath-B, respectively (I). The cleav- age products were separated by SDS-PAGE and stained with Coomassie blue. B, Reverse phase-HPLC profile of the cleavage products of CCL20 after Cath-D and Cath-B processing. C, CCL20 cleavage sites for Cath-D and Cath-B. The positions of the amino acids located at the cleavage sites are indicated.

Article Snippet: Biotinylated goat anti-human CCL20 was from R&D Systems.

Techniques: Incubation, Inhibition, SDS Page, Staining

FIGURE 4. Expression of CCL20 in melanoma cell lines and human malignant melanoma. A, RT-PCR analysis of CCL20 and G3PDH expres- sion in melanoma cell lines A375, A2058, and SK-MEL-2. Positive control RT-PCR products were obtained from primary keratinocytes (Prim. Ker- atin.), human keratinocyte cell line (NCTC 2544), and Caco-2 cells. A 100-base DNA ladder (ladder) and a negative control (no cDNA; control ) are shown. B, Localization of CCL20 transcripts in human malignant melanoma by in situ hybridization. Hybridization signals of antisense CCL20 riboprobes are identified in keratinocytes and melanoma cells. No signals were detected in serial sections hybridized with the sense probe.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing.

doi: 10.4049/jimmunol.176.11.6512

Figure Lengend Snippet: FIGURE 4. Expression of CCL20 in melanoma cell lines and human malignant melanoma. A, RT-PCR analysis of CCL20 and G3PDH expres- sion in melanoma cell lines A375, A2058, and SK-MEL-2. Positive control RT-PCR products were obtained from primary keratinocytes (Prim. Ker- atin.), human keratinocyte cell line (NCTC 2544), and Caco-2 cells. A 100-base DNA ladder (ladder) and a negative control (no cDNA; control ) are shown. B, Localization of CCL20 transcripts in human malignant melanoma by in situ hybridization. Hybridization signals of antisense CCL20 riboprobes are identified in keratinocytes and melanoma cells. No signals were detected in serial sections hybridized with the sense probe.

Article Snippet: Biotinylated goat anti-human CCL20 was from R&D Systems.

Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Positive Control, Negative Control, Control, In Situ Hybridization, Hybridization

FIGURE 7. Cleavage of CCL20 by melanoma cell lines. A, Processing of CCL20 by membranes of A375 (1), A2058 (2), and SK-MEL-2 (3) cells. CCL20 (5 M) was incubated for 4 h at 37°C with membrane equivalents of 3 105 cells in 50 mM sodium citrate, 50 mM NaCl (pH 4.0), and pepstatin A as indicated. The cleavage products were separated by SDS-PAGE and stained with Coomassie blue. The molecular masses of intact CCL201–70 and CCL201–55 after Cath-D cleavage are 8025 and 6224 Da, respectively (arrows). B, Processing of CCL20 by purified Cath-B (left panel) or Cath-D (middle panel) for 1.5 h or membranes of SK-MEL-2 cells (right panel) for 4 h at pH 4.0 in presence of CA-074 and pepstatin A as indicated. The molecular masses of intact CCL201–70, CCL201–66 after Cath-B cleavage and CCL201–55 after Cath-D cleavage are 8025, 7552, and 6224 Da, respectively (arrows). C, As in A but incubation was with PBS containing 4 mM EDTA, 2 mM L-cysteine, 0.1% Triton X-100 (pH 6.8). D, Processing of CCL20 by conditioned medium of SK-MEL-2 cells. Conditioned medium was concentrated (2.5) and incubated with CCL20 (5 M) at pH 4.0 for the indicated times and in the presence of pepstatin A (left panel). Coomassie blue staining of CCL20 incubated for 8 h with purified Cath-D or conditioned medium is shown in the middle panel. The right panel shows migration in response to increasing concentrations of CCL20 after incubation for 8 h in conditioned medium with or without pepstatin A. Results are expressed as means SD of the numbers of cells observed per five high-power fields. A representative experiment of three is shown. IB, Immunoblotting; Cond. medium, conditioned medium.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing.

doi: 10.4049/jimmunol.176.11.6512

Figure Lengend Snippet: FIGURE 7. Cleavage of CCL20 by melanoma cell lines. A, Processing of CCL20 by membranes of A375 (1), A2058 (2), and SK-MEL-2 (3) cells. CCL20 (5 M) was incubated for 4 h at 37°C with membrane equivalents of 3 105 cells in 50 mM sodium citrate, 50 mM NaCl (pH 4.0), and pepstatin A as indicated. The cleavage products were separated by SDS-PAGE and stained with Coomassie blue. The molecular masses of intact CCL201–70 and CCL201–55 after Cath-D cleavage are 8025 and 6224 Da, respectively (arrows). B, Processing of CCL20 by purified Cath-B (left panel) or Cath-D (middle panel) for 1.5 h or membranes of SK-MEL-2 cells (right panel) for 4 h at pH 4.0 in presence of CA-074 and pepstatin A as indicated. The molecular masses of intact CCL201–70, CCL201–66 after Cath-B cleavage and CCL201–55 after Cath-D cleavage are 8025, 7552, and 6224 Da, respectively (arrows). C, As in A but incubation was with PBS containing 4 mM EDTA, 2 mM L-cysteine, 0.1% Triton X-100 (pH 6.8). D, Processing of CCL20 by conditioned medium of SK-MEL-2 cells. Conditioned medium was concentrated (2.5) and incubated with CCL20 (5 M) at pH 4.0 for the indicated times and in the presence of pepstatin A (left panel). Coomassie blue staining of CCL20 incubated for 8 h with purified Cath-D or conditioned medium is shown in the middle panel. The right panel shows migration in response to increasing concentrations of CCL20 after incubation for 8 h in conditioned medium with or without pepstatin A. Results are expressed as means SD of the numbers of cells observed per five high-power fields. A representative experiment of three is shown. IB, Immunoblotting; Cond. medium, conditioned medium.

Article Snippet: Biotinylated goat anti-human CCL20 was from R&D Systems.

Techniques: Incubation, Membrane, SDS Page, Staining, Migration, Western Blot